Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vassal

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Acta Neurochirurgica|January 1, 1990
Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivorsE Suc, C Kalifa, R Brauner, et al.
British Journal of Cancer|April 17, 1999
Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in childrenH Avet-Loiseau, A M Vénuat, M J Terrier-Lacombe, et al.
Bulletin Du Cancer|January 26, 1999
[Carboxypeptidase-G2 rescue of methotrexate intoxication]J Grill, M E Amigo-Ferreiro, C Schoepfer, et al.
Bone Marrow Transplantation|May 9, 2000
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastomaD Valteau-Couanet, E Benhamou, G Vassal, et al.
Bone Marrow Transplantation|August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in childrenJ Grill, M C Le Deley, D Valteau-Couanet, et al.
Bone Marrow Transplantation|April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastomaD Valteau-Couanet, G Vassal, C Pondarré, et al.
Blood|May 1, 1992
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?G Vassal, A Deroussent, D Challine, et al.
Endocrinology|August 31, 2000
Establishment and characterization of a human adrenocortical carcinoma xenograft modelA Logié, P Boudou, L Boccon-Gibod, et al.
British Journal of Cancer|September 11, 2003
Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activityC Cherbonnier, O Déas, G Carvalho, et al.
British Journal of Cancer|February 5, 2004
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 casesV Minard-Colin, C Kalifa, J-M Guinebretiere, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Acta Neurochirurgica|January 1, 1990
Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivorsE Suc, C Kalifa, R Brauner, et al.
British Journal of Cancer|April 17, 1999
Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in childrenH Avet-Loiseau, A M Vénuat, M J Terrier-Lacombe, et al.
Bulletin Du Cancer|January 26, 1999
[Carboxypeptidase-G2 rescue of methotrexate intoxication]J Grill, M E Amigo-Ferreiro, C Schoepfer, et al.
Bone Marrow Transplantation|May 9, 2000
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastomaD Valteau-Couanet, E Benhamou, G Vassal, et al.
Bone Marrow Transplantation|August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in childrenJ Grill, M C Le Deley, D Valteau-Couanet, et al.
Bone Marrow Transplantation|April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastomaD Valteau-Couanet, G Vassal, C Pondarré, et al.
Blood|May 1, 1992
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?G Vassal, A Deroussent, D Challine, et al.
Endocrinology|August 31, 2000
Establishment and characterization of a human adrenocortical carcinoma xenograft modelA Logié, P Boudou, L Boccon-Gibod, et al.
British Journal of Cancer|September 11, 2003
Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activityC Cherbonnier, O Déas, G Carvalho, et al.
British Journal of Cancer|February 5, 2004
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 casesV Minard-Colin, C Kalifa, J-M Guinebretiere, et al.
Pageof 10